# An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus Erythematosus

> **NCT06945068** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 19 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **BIOLOGICAL:** GB261

## Key facts

- **NCT ID:** NCT06945068
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2025-06
- **Final completion:** 2026-11-30
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06945068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06945068, "An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06945068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*